Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price shot up 0.1% on Wednesday . The company traded as high as $0.28 and last traded at $0.27. 2,182,896 shares changed hands during mid-day trading, an increase of 295% from the average session volume of 551,962 shares. The stock had previously closed at $0.27.
Cybin Stock Down 2.0 %
The firm has a 50 day moving average price of $0.34 and a two-hundred day moving average price of $0.38. The company has a market capitalization of $39.62 million and a price-to-earnings ratio of -1.11.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Stories
- Five stocks we like better than Cybin
- Where to Find Earnings Call Transcripts
- Dell and Super Micro Computer: Musk’s Favorite AI Hardware Stocks
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Top 3 Home Builder Stocks: Key Insights into the Housing Market
- How to Most Effectively Use the MarketBeat Earnings Screener
- Is Advanced Micro Devices Stock Ready for Another Run?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
